Does Combined Clinical and Ultrasound Assessment Allow Selection of Individuals With Rheumatoid Arthritis for Sustained Reduction of Anti–Tumor Necrosis Factor Therapy?
Jonathan L. Marks(University Hospital Southampton NHS Foundation Trust), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Elaine Dennison(MRC Lifecourse Epidemiology Unit), Antonia Calogeras, Borislav D. Dimitrov(Medical University Pleven), Cyrus Cooper(University Hospital Southampton NHS Foundation Trust), Brian Davidson(University Hospital Southampton NHS Foundation Trust), Christopher Holroyd(Southampton General Hospital), Ray Armstrong(University Hospital Southampton NHS Foundation Trust), Nicholas C. Harvey(University Hospital Southampton NHS Foundation Trust)
Cited by 31
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k